Click here to increase the text size or to change the website to high contrast for easier viewing. If at any stage you need to change the text back or increase the size again, please click ‘TEXT SIZE’ on the top right hand corner.
This window will close after 20 seconds
15 February, 2012
Walking speed and hand-grip strength during middle age correlated with cognitive function and stroke risk in older adults, suggesting simple tests might aid diagnosis of the two conditions, according to data from a large cohort study.
By Charles Bankhead, Staff Writer, MedPage Today
2 January, 2012
Scientists have identified a cell population that is a primary target of the degenerative brain disease known as frontotemporal dementia (FTD), which is as common as Alzheimer’s disease in patients who develop dementia before age 65. Because the cells arose only recently in
2 January, 2012
Sensible Science promoted
British scientists concerned about celebrities' ability to affect public opinion by promoting unproven or dubious health therapies, scientific theories, and campaigns have mounted a campaign to provide information on basic science dos and don
2 January, 2012
Nutritionists recommend fish as part of a healthy diet, and now research shows that omega-3 fatty acids found in the oil of certain fish may also benefit the brain by lowering the risk of dementia. In order to test whether an omega-3 fatty acid can affect the progression of AD, researchers at
2 January, 2012
Researchers are getting closer to understanding how Alzheimer’s disease develops and a key component in several emerging theories is insulin and its role in the brain. One reason uncovering the role of insulin in Alzheimer’s disease is exciting is because drugs already exist to treat insulin
2 January, 2012
A number of environmental factors have been put forward as possible contributory causes of Alzheimer's disease in some people. Among these is aluminium. There is circumstantial evidence linking this metal with Alzheimer's disease but no causal relationship has yet been proved. As evidence for
2 January, 2012
by John O'Brien
Dementia currently affects around 25 million people worldwide and the number is set to rise to more than 80 million over the next 30 years. During the past decade, the advent of pharmacological treatments for Alzheimer's disease (AD), which is the cause of two-thirds of
2 January, 2012
Frederick Henry Lewey (born Friedrich Heinrich Lewy on 28 January 1885 in Berlin, died 5 October 1950 in Haverford, Pennsylvania) was a prominent neurologist. He is best known for the discovery of Lewy bodies, which are a characteristic indicator of Parkinson's disease and Dementia
2 January, 2012
Drs Tom Brittain and Joanna Skommer of the University of Auckland’s School of Biological Sciences, working in collaboration with Dr Subadhip Raychaudhuri at the University of California, Davis, have discovered that the protein neuroglobin may protect against diseases such as Alzheimer’s by
2 January, 2012
Aβ is the main component of amyloid plaques* which are present in the brains of Alzheimer’s patients. The protein is thought to cause behavioural and cognitive impairment due to the damage and death of neurons in the critical memory and navigational part of the brain called the hippocampus.
Print
PDF